UBS ASSET MANAGEMENT AMERICAS LLC - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 90 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 15.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$188,358,000
-54.8%
38,917
-0.7%
0.00%
Q4 2019$416,803,000
+27.2%
39,210
+24.6%
0.00%
Q3 2019$327,551,000
+20.2%
31,465
+76.9%
0.00%
Q2 2019$272,497,000
+19.2%
17,7870.0%0.00%
Q1 2019$228,563,000
+12762.3%
17,787
+9411.8%
0.00%
Q4 2018$1,777,000
-42.8%
1870.0%0.00%
Q3 2018$3,104,000
+3.4%
1870.0%0.00%
Q2 2018$3,001,0001870.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 453,000$4,168,0001.58%
Eventide Asset Management 1,086,400$9,995,0000.62%
SPHERA FUNDS MANAGEMENT LTD. 300,000$2,760,0000.47%
Lyon Street Capital, LLC 125,595$1,155,0000.46%
CARL DOMINO INC 26,000$239,0000.28%
PURA VIDA INVESTMENTS, LLC 60,000$552,0000.22%
KNOTT DAVID M 41,692$384,0000.16%
SABBY MANAGEMENT, LLC 187,500$1,725,0000.11%
FARALLON CAPITAL MANAGEMENT LLC 1,157,500$10,649,0000.11%
Telemetry Investments, L.L.C. 25,000$230,0000.11%
View complete list of STEMLINE THERAPEUTICS INC shareholders